In an EAP, a healthcare provider can request access to an investigational drug on behalf of a patient. The pharmaceutical company that manufactures the drug must agree to provide it, and the regulatory authority must approve the request. Typically, the process involves a detailed application that includes the patient's medical history and justification for the need for the investigational drug. The primary goal is to ensure that the potential benefits outweigh the risks.
